Owlet, Inc.
NYSE:OWLTMedical - Devices
+$0.46 today
- Market cap
- $107.24M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
Volume 0.64M
Average 0.24M
OWLT Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Owlet, Inc.NYSE: OWLT
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin growth accelerates
Q1 FY2026 selling, general & admin of $13.78M rose 24.2% year over year, ahead of the -0.9% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 0.7% from the prior quarter. Over 3 fiscal years it compounded at -15.8% a year.
Context
- Selling, general & admin amounted to 45.1% of revenue in FY2025, down 18.6 pp from a year earlier.
- Selling, general & admin increased in 1 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 3 analysts of $88.38M (+85.2%) for the fiscal year ending Dec 2026, a step up from the -4.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $13.78M-0.7% QoQ
- Last fiscal yearDec 2025
- $47.72M-4.0% YoY
- LTMMar 2026
- $50.4M-0.9% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 47.72M USD
- Year-over-year change
- -4.0%
- 4-year CAGR
- -8.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.72M | -4.0% |
| FY2024 | 2024-12-31 | 49.73M | +21.7% |
| FY2023 | 2023-12-31 | 40.87M | -48.9% |
| FY2022 | 2022-12-31 | 80.04M | +15.3% |
| FY2021 | 2021-12-31 | 69.42M | — |
Selling, General & Admin vs competitors
How OWLT compares with its peers on the latest reported figures
- OWLT's LTM Mar 2026 selling, general & admin of $50.4M is the 3rd highest of the 10 companies compared; the peer median is $36.54M.
- Its year-over-year change of -0.9% is the 8th highest of 10, against a peer median of +20.3%.
- Selling, general & admin amounts to 47.1% of revenue for OWLT, versus a peer median of 130.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $20.08B | +51937.5% | +914.5% | 391112.6% | |
| LTM Mar 2026 | $53.95M | +26.2% | -1.4% | 46.4% | |
| LTM Mar 2026 | $50.4M | -0.9% | -15.8% | 47.1% | |
| LTM Mar 2026 | $42.18M | -24.8% | +1.9% | 130.7% | |
| LTM Mar 2026 | $37.26M | +7.2% | -5.9% | 108.4% | |
| LTM Mar 2026 | $36.54M | +18.5% | +18.5% | 63.3% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $15.75M | +155.8% | +17.1% | 850.8% |
| LTM Mar 2026 | $15.52M | -5.5% | -6.6% | — | |
ELTXElicio Therapeutics, Inc. | LTM Mar 2026 | $13.7M | +20.3% | +31.5% | — |
| LTM Mar 2026 | $13.02M | +27.1% | +2.6% | 2479.6% | |
| Peer median (excluding OWLT) | $36.54M | +20.3% | +2.6% | 130.7% | |
Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 75.84M | 69.2M | 54.01M | 78.06M | 105.71M |
| Cost of Revenue | 40.78M | 45.89M | 31.42M | 38.75M | 52.18M |
| Gross Profit | 35.06M | 23.31M | 22.59M | 39.31M | 53.53M |
| Gross Margin | 46.2% | 33.7% | 41.8% | 50.4% | 50.6% |
| Research & Development | 21.43M | 27.9M | 10.35M | 9.8M | 14.08M |
| Selling, General & Admin | 69.42M | 80.04M | 40.87M | 49.73M | 47.72M |
| Operating Expenses | 90.85M | 107.93M | 51.22M | 59.53M | 61.79M |
| Depreciation & Amortization | 1.13M | 2.67M | 2.21M | 1.38M | 590K |
| EBITDA | (42.71M) | (75.53M) | (27.49M) | (9.47M) | (35.64M) |
| EBITDA Margin | -56.3% | -109.1% | -50.9% | -12.1% | -33.7% |
| Operating Income | (55.79M) | (84.62M) | (28.63M) | (20.22M) | (8.26M) |
| Operating Margin | -73.6% | -122.3% | -53.0% | -25.9% | -7.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 27.83M | 1.1M | 3.19M | 1.63M | 3.42M |
| Other Income / Expenses | (15.88M) | 5.31M | (4.26M) | 7.74M | (31.39M) |
| Income Before Tax | (71.67M) | (79.31M) | (32.89M) | (12.48M) | (39.65M) |
| Pre-Tax Margin | -94.5% | -114.6% | -60.9% | -16.0% | -37.5% |
| Income Tax Expense | 31K | 29K | 10K | 54K | 28K |
| Net Income | (71.7M) | (79.34M) | (32.9M) | (12.54M) | (39.68M) |
| Net Margin | -94.5% | -114.6% | -60.9% | -16.1% | -37.5% |
| EPS (Basic) | (12.47) | (9.97) | (4.53) | (0.83) | (2.24) |
| EPS (Diluted) | (12.47) | (9.97) | (4.53) | (0.83) | (2.24) |
| Weighted Avg Shares | 7.87M | 7.95M | 8.28M | 15.11M | 562.5M |
| Weighted Avg Shares (Diluted) | 7.87M | 7.95M | 8.28M | 15.11M | 562.5M |
Owlet, Inc.
NYSE:OWLT
Intrinsic Alpha fair value
Locked
Current Price
$3.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.